CMCER
المركز الكندي الطبيTechnical Analysis & Signals
Canadian Medical Center stock is experiencing a downward trend with negative signals in technical analysis.
Technical Analysis
Technical analysis indicates that the stock is in a downtrend, trading below the 50-day and 200-day moving averages. The Relative Strength Index (RSI) at 39.1 suggests an oversold condition, reflecting weakness in upward momentum.
Support & Resistance Levels
The main support level for the stock is at 5.33 SAR, while the resistance level is at 5.67 SAR. The stock may head towards the support level if the downtrend persists.
Volume Analysis
Volume data has not been provided, but a decrease in trading volume is expected as the price declines. Lower volume may indicate weakness in the current downtrend.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 39.6, indicating a relatively high valuation. The dividend yield at 15.93% may attract some investors, but the current price performance could negatively impact confidence.
Risk Factors
Risks include the ongoing downtrend and the possibility of breaking the support level. Additionally, general economic factors in the Saudi market may impact the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. It is advisable to monitor market developments and analyze data regularly before making any investment decisions.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - CMCER
4021Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 427.35M
- P/E Ratio
- 39.60
- P/B Ratio
- 4.50
- EPS (Earnings/Share)
- 0.14
Profitability
- Revenue
- 148.23M
- Net Income
- 10.50M
- Return on Equity (ROE)
- +10.00%
- Shares Outstanding
- 77.00M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 6.02M
- Debt/Equity
- 6.26
- Free Float %
- +51.5%
Dividends & Margins
- Dividend Yield
- +15.93%
- Dividend/Share
- 0.90
- Book Value
- 1.23
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 148.23M +33.8% | 10.50M +2.2% | 133.00M +11.0% | 6.02M -17.8% | 0.14 +7.7% |
| 2024 | 110.80M +10.4% | 10.27M -34.6% | 119.88M +6.8% | 7.32M +67.1% | 0.13 -35.0% |
| 2023 | 100.34M +23.5% | 15.71M +0.4% | 112.25M +3.3% | 4.38M -15.7% | 0.20 0.0% |
| 2022 | 81.23M | 15.65M | 108.69M | 5.19M | 0.20 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
CMCER gets SAR 22M credit facility from Riyad Bank
CMCER reappoints Khalid Al-Ammar as Chairman, Hamad Al-Dhuwaili as Deputy
CMCER extends Johns Hopkins Aramco’s SAR 45.6M contract
CMCER transitions to TASI, begins trading at SAR 9.05
United Securities issues Q4 2025 earnings forecasts
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
A look on Nomu performance YTD, new listings
Nomu sees 8 resignations of chairmen, CEOs in 2023
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 249.10 SAR | |
| 4002 | Mouwasat | 71.10 SAR | |
| 4004 | Dallah Healthcare | 124.60 SAR | |
| 4017 | Fakeeh Care | 32.40 SAR | |
| 4018 | Almoosa | 137.10 SAR | |
| 4005 | CARE | 130.70 SAR | |
| 4019 | SMC Healthcare | 17.70 SAR | |
| 4007 | Alhammadi | 25.72 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-03-26
Risk Assessment
Risk Factors
Average True Range 4.5% of stock price
Trading volume near or above average
P/E ratio 39.6 — above average
Debt-to-equity ratio 6.26
ADX indicator at 21
High volatility and financial pressures requiring careful monitoring
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is CMCER stock price today?
CMCER (4021) stock price today is 5.55 SAR, declining by -1.77% compared to the previous session close. The 52-week price range is between 5.33 SAR and 9.30 SAR.
2 What is CMCER stock valuation?
The automated analysis signal for CMCER is "Sell" with 65% confidence. The P/E ratio is 39.6. The P/B ratio is 4.50.
3 Is CMCER Shariah-compliant?
Yes, CMCER (4021) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are CMCER dividend distributions?
CMCER has a dividend yield of 15.93%, with an estimated annual dividend of 0.90 SAR per share.
5 What is CMCER weekly performance?
CMCER performance over different time periods: weekly change -0.89%, monthly -10.34%, and year-to-date -10.05%. The stock is currently trading with a volume of 1,092,834 shares.
6 What is the target level for CMCER?
According to automated analysis for CMCER: Short-term target (1-2 weeks): 5.40 SAR. Support level: 5.33 SAR. Resistance level: 5.67 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.